LL M22 (Methyldopa 250 MG)
Pill imprint LL M22 has been identified as Methyldopa 250 MG.
Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LL M22
- Strength:
- 250 MG
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Lederle Laboratories
More about methyldopa
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents, centrally acting
Consumer resources
Other brands: Aldomet
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
